Remove 2022 Remove Animal Testing Remove Biosimilars
article thumbnail

Exploring alternatives to animal testing in drug discovery

Drug Target Review

Animal testing plays a significant role in pre-clinical research and therefore requires the use of millions of animals. million scientific procedures involving live animals were carried out in 2020. million scientific procedures involving live animals were carried out in 2020. In Britain, 2.88 In Britain, 2.88

article thumbnail

Rapid delivery of toxicological material

Drug Target Review

Relatively recently, the concept of non-animal studies for toxicology data generation has been discussed and Food and Drug Administration (FDA) guidance in this direction was issued in December 2022. 1 The concept of in-silico models as surrogate for animal models is also an option for drug developers to generate initial safety data.

article thumbnail

The FDA Modernization Act 2.0: The End of IND-Enabling Toxicology Studies?

The Premier Consulting Blog

This act amends the Federal Food, Drug, and Cosmetic Act (FFDCA), which applies to new drugs, and the Public Health Service Act, which applies to biosimilars. As a result, the FDA is now required to consider alternatives to animal testing, such as in vitro , in silico , and in chemico tests and models.

FDA 52